SPECIFICATION
Generics
Levodopa , Carbidopa , Entacapone
Used For
Anti-Parkinson
Indication
• Levodopa + Carbidopa + Entacapone is indicated for the treatment of Parkinson’s disease. Levodopa + Carbidopa + Entacapone can be used: • To substitute (with equivalent strengths of each of the three components) carbidopa, levodopa and entacapone previously administered as individual products. • To replace carbidopa/levodopa therapy (without entacapone) when patients experience the signs and symptoms of end-of-dose “wearing-off” and when they have been taking a total daily dose of levodopa of 600mg or less and have not been experiencing dyskinesias.
Reviews
There are no reviews yet.